Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)
PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...
Social media goes wild for 'unbelievable' plastic surgery transformations that turn ordinary women into supermodels - but surgeon is under fire
Dr Farzan Malekzadeh, owner of FMX beauty based in Turkey, who goes by @Dr.FrzmkZ on social media, says his transformations ...
Legit on MSN18h
Top 10 mistakes that could ruin your JAMB 2025 registration
Over the years, there are constant pitfalls JAMB candidates fall into during the registration window for the pre-admission ...